Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CNPY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR4640 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUD31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPUSD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX6C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060373 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMAN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on